Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine
Objective: To assess virological and immunological responses and toxicity in subjects
receiving combination antiretroviral therapy. Design: Six-year follow-up of a single arm of a …
receiving combination antiretroviral therapy. Design: Six-year follow-up of a single arm of a …
Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy
Background The new protease inhibitors are potent inhibitors of the human
immunodeficiency virus (HIV), and in combination with other antiretroviral drugs they may be …
immunodeficiency virus (HIV), and in combination with other antiretroviral drugs they may be …
Virological and immunological effects of combination antiretroviral therapy with zidovudine, lamivudine, and indinavir during primary human immunodeficiency virus …
D Smith, MM Berrey, M Robertson… - The Journal of …, 2000 - academic.oup.com
Forty-seven patients presenting with primary human immunodeficiency virus (HIV) infection
were treated with zidovudine 200 mg 3 times a day, lamivudine 150 mg 2 times a day, and …
were treated with zidovudine 200 mg 3 times a day, lamivudine 150 mg 2 times a day, and …
[HTML][HTML] A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic …
SM Hammer, KE Squires, MD Hughes… - … England Journal of …, 1997 - Mass Medical Soc
Background The efficacy and safety of adding a protease inhibitor to two nucleoside
analogues to treat human immunodeficiency virus type 1 (HIV-1) infection are not clear. We …
analogues to treat human immunodeficiency virus type 1 (HIV-1) infection are not clear. We …
A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral …
M Hirsch, R Steigbigel, S Staszewski… - The Journal of …, 1999 - academic.oup.com
A randomized, double-blind, multicenter study of indinavir, zidovudine, and lamivudine was
conducted in 320 adults with human immunodeficiency virus type 1 (HIV-1) infection,⩽ 50 …
conducted in 320 adults with human immunodeficiency virus type 1 (HIV-1) infection,⩽ 50 …
Predictors of Virologic and Clinical Outcomes in HIV-1–Infected Patients Receiving Concurrent Treatment with Indinavir, Zidovudine, and Lamivudine: AIDS Clinical …
LM Demeter, MD Hughes, RW Coombs… - Annals of internal …, 2001 - acpjournals.org
Background: A substantial proportion of patients with HIV infection will not respond to
antiretroviral therapy. Early predictors of response to treatment are needed to identify …
antiretroviral therapy. Early predictors of response to treatment are needed to identify …
[HTML][HTML] Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy
DV Havlir, IC Marschner, MS Hirsch… - … England Journal of …, 1998 - Mass Medical Soc
Background Combination antiretroviral therapy with indinavir, zidovudine, and lamivudine
can suppress the level of human immunodeficiency virus (HIV) RNA in plasma below the …
can suppress the level of human immunodeficiency virus (HIV) RNA in plasma below the …
Correspondence between the effect of zidovudine plus lamivudine on plasma HIV level/CD4 lymphocyte count and the incidence of clinical disease in infected …
AN Phillips, J Eron, J Bartlett, DR Kuritzkes… - AIDS, 1997 - journals.lww.com
Objectives: To investigate whether apparently beneficial changes in plasma HIV RNA level
and CD4 lymphocyte count that are induced by antiretroviral therapy are associated with a …
and CD4 lymphocyte count that are induced by antiretroviral therapy are associated with a …
Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up
Context.—Combination antiretroviral therapy can markedly suppress human
immunodeficiency virus (HIV) replication but the duration of HIV suppression varies among …
immunodeficiency virus (HIV) replication but the duration of HIV suppression varies among …
Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical …
Abstract Human immunodeficiency virus (HIV)-1 infection is associated with progressive cell-
mediated immune deficiency and abnormal immune activation. Although highly active …
mediated immune deficiency and abnormal immune activation. Although highly active …